<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>Diarrhea and other gastrointestinal symptoms are possible side effects of long-term antibiotic therapy. The most common etiology of hospital-acquired diarrhea is <italic>Clostridium difficile</italic> infection (CDI). It has been demonstrated that probiotic use may be beneficial in the prevention of antibiotic-associated diarrhea. There is also growing evidence that a fecal microbiota transplant may reduce the duration and recurrence of CDI. In this review, we update the current knowledge on both modalities in the prevention of resistant CDI and as useful adjuncts to standard treatment.</p>
</abstract>

Diarrhea and other gastrointestinal symptoms are possible side effects of long-term antibiotic therapy. The most common etiology of hospital-acquired diarrhea is Clostridium difficile infection (CDI). It has been demonstrated that probiotic use may be beneficial in the prevention of antibiotic-associated diarrhea. There is also growing evidence that a fecal microbiota transplant may reduce the duration and recurrence of CDI. In this review, we update the current knowledge on both modalities in the prevention of resistant CDI and as useful adjuncts to standard treatment.

Manipulation of the gut microbiota: probiotics and fecal microbiota transplantation as a treatment option for recurrent <italic>Clostridium difficile</italic> infection

Pomeranian Medical University in Szczecin

Department of Nephrology, Transplantology and Internal Medicine

Pomeranian Journal of Life Sciences

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Manipulation of the gut microbiota: probiotics and fecal microbiota transplantation as a treatment option for recurrent  infection

Diarrhea and other gastrointestinal symptoms are possible side effects of long-term antibiotic therapy. The most common etiology of hospital-acquired diarrhea...

Manipulation of the gut microbiota: probiotics and fecal microbiota transplantation as a treatment option for recurrent Clostridium difficile infection

Pubblicato online: 18 gen 2022

Pagine: 14 - 16

DOI: https://doi.org/10.21164/pomjlifesci.757

Parole chiave
fecal microbiota transplantation, clostridium difficile, probiotics, microbiome, microbiota

© 2021 Wiktoria Feret et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Manipulation of the gut microbiota: probiotics and fecal microbiota transplantation as a treatment option for recurrent Clostridium difficile infection

Pubblicato online: 18 gen 2022

Pagine: 14 - 16

DOI: https://doi.org/10.21164/pomjlifesci.757

Parole chiavefecal microbiota transplantation, clostridium difficile, probiotics, microbiome, microbiota

© 2021 Wiktoria Feret et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Parole chiave
fecal microbiota transplantation, clostridium difficile, probiotics, microbiome, microbiota